Bank of New York Mellon Corp - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 378 filers reported holding ENCOMPASS HEALTH CORP in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q2 2024$129,843,939
-3.4%
1,513,509
-7.0%
0.02%
-3.8%
Q1 2024$134,420,339
+14.0%
1,627,759
-7.9%
0.03%
+8.3%
Q4 2023$117,884,351
-2.9%
1,766,852
-2.3%
0.02%
-11.1%
Q3 2023$121,417,042
-3.0%
1,807,877
-2.2%
0.03%
+3.8%
Q2 2023$125,169,512
+10.1%
1,848,612
-12.0%
0.03%
+4.0%
Q1 2023$113,647,978
-9.8%
2,100,702
-0.2%
0.02%
-13.8%
Q4 2022$125,939,937
+26.2%
2,105,667
-4.6%
0.03%
+20.8%
Q3 2022$99,811,000
-13.4%
2,206,712
+7.3%
0.02%
-7.7%
Q2 2022$115,297,000
-22.8%
2,057,035
-2.0%
0.03%
-10.3%
Q1 2022$149,314,000
+45.3%
2,099,763
+33.3%
0.03%
+52.6%
Q4 2021$102,783,000
-8.4%
1,574,997
+5.3%
0.02%
-13.6%
Q3 2021$112,239,000
-4.2%
1,495,746
-0.3%
0.02%
-4.3%
Q2 2021$117,112,000
-4.7%
1,500,863
+0.0%
0.02%
-8.0%
Q1 2021$122,877,000
+2.0%
1,500,327
+3.0%
0.02%
-3.8%
Q4 2020$120,457,000
+16.9%
1,456,714
-8.2%
0.03%
+4.0%
Q3 2020$103,062,000
-9.9%
1,586,036
-14.1%
0.02%
-19.4%
Q2 2020$114,377,000
+8.9%
1,846,892
+12.6%
0.03%
-11.4%
Q1 2020$105,037,000
+17.2%
1,640,449
+26.8%
0.04%
+52.2%
Q4 2019$89,641,000
+9.5%
1,294,082
+0.1%
0.02%
+4.5%
Q3 2019$81,830,000
-3.5%
1,293,162
-3.3%
0.02%
-4.3%
Q2 2019$84,755,000
-1.1%
1,337,673
-8.9%
0.02%
-4.2%
Q1 2019$85,723,000
-6.8%
1,467,839
-1.5%
0.02%
-17.2%
Q4 2018$91,986,000
-17.7%
1,490,866
+4.0%
0.03%0.0%
Q3 2018$111,731,000
+16.9%
1,433,372
+1.5%
0.03%
+11.5%
Q2 2018$95,594,000
+5.9%
1,411,606
-10.6%
0.03%
+4.0%
Q1 2018$90,286,0001,579,2650.02%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 697,659$45,334,00010.13%
JANA PARTNERS LLC 1,741,513$113,164,00010.12%
Endurant Capital Management LP 276,105$17,941,0005.31%
REINHART PARTNERS, LLC. 726,140$47,184,0003.55%
Prosight Management, LP 107,921$7,013,0003.34%
Advantage Alpha Capital Partners LP 160,234$10,412,0002.41%
RK Capital 115,800$7,525,0002.13%
Copeland Capital Management, LLC 700,015$45,487,0002.02%
Sivik Global Healthcare LLC 65,000$4,224,0001.82%
Walthausen & Co., LLC 120,016$7,799,0001.62%
View complete list of ENCOMPASS HEALTH CORP shareholders